Actively Recruiting
"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"
Led by Fayoum University · Updated on 2025-09-11
90
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)
CONDITIONS
Official Title
"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with diagnosed ischemic heart failure confirmed by a primary care provider
- Patients currently using statin and SGLT2i medications
- Patients aged between 50 and 80 years
- Patients willing to provide written informed consent
You will not qualify if you...
- Patients with liver dysfunction
- Patients with renal dysfunction
- Patients with fungal infections
- Patients with coagulation disorders
- Patients using drugs that interact with SGLT2i
- Patients who refuse to participate or decline to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asmaa mohamed abdelkader
Al Fayyum, Faiyum Governorate, Egypt
Actively Recruiting
Research Team
R
Raghda Roshdy
CONTACT
M
Marwa Kamal
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here